StreetInsider.com News Articles

Form 144 MACROGENICS INC Filed by: Spitznagel Thomas

Mon, 13 Jul 2026 21:26:00 -0400

si-local-file:///var/storage/secattach/20260713/26763525.html

Form 144 MACROGENICS INC Filed by: Spitznagel Thomas

Mon, 13 Jul 2026 21:26:00 -0400

si-local-file:///var/storage/secattach/20260713/26763525.html

Karen Ferrante to resign from MacroGenics board in September

Wed, 08 Jul 2026 16:02:48 -0400

Karen Ferrante, M.D. notified the board of directors of MacroGenics, Inc. (NASDAQ: MGNX) of her decision to resign from the board, effective September 1, 2026.

According to a statement from the company, Ferrante's resignation is for personal reasons and is not the result of any disagreement with the company or any matter relating to its operations, policies, or practices.

Karen Ferrante to resign from MacroGenics board in September

Wed, 08 Jul 2026 16:02:48 -0400

Karen Ferrante, M.D. notified the board of directors of MacroGenics, Inc. (NASDAQ: MGNX) of her decision to resign from the board, effective September 1, 2026.

Form 8-K MACROGENICS INC For: Jul 01

Wed, 08 Jul 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260708/26747466.html

Form 8-K MACROGENICS INC For: Jul 01

Wed, 08 Jul 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260708/26747466.html

MacroGenics sells CDMO operations to Bora Pharmaceuticals for $122.5M

Tue, 07 Jul 2026 16:34:57 -0400

MacroGenics, Inc. (NASDAQ: MGNX) completed the sale of its contract development and manufacturing organization (CDMO) operations to Bora Pharmaceuticals Co., Ltd. and Bora Biologics USA, LLC on June 30, 2026.

The transaction, originally announced via an Asset Purchase Agreement dated May 11, 2026, involved the transfer of assets and liabilities related to MacroGenics' GMP manufacturing operations at its Rockville, Maryland facility and a related warehouse in Frederick, Maryland. Research and related assets were excluded from the sale.

Bora Pharmaceuticals, a Taiwan-based company, along with its U.S. affiliate paid MacroGenics $122.5 million before transaction fees and expenses. The final amount is subject to

MacroGenics sells CDMO operations to Bora Pharmaceuticals for $122.5M

Tue, 07 Jul 2026 16:34:57 -0400

Bora Pharmaceuticals, a Taiwan-based company, along with its U.S. affiliate paid MacroGenics $122.5 million before transaction fees and expenses. The final amount is subject to

Form 8-K MACROGENICS INC For: Jun 30

Tue, 07 Jul 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260707/26742137.html

Form 8-K MACROGENICS INC For: Jun 30

Tue, 07 Jul 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260707/26742137.html

MacroGenics sells GMP manufacturing unit to Bora for $122.5M

Thu, 02 Jul 2026 09:25:23 -0400

MacroGenics, Inc. (NASDAQ: MGNX) has completed the sale of its good manufacturing practice (GMP) drug substance manufacturing operations to Bora Pharmaceuticals Co., Ltd. (TWSE: 6472; OTCQX: BORAY) for $122.5 million, before transaction fees and expenses and subject to customary post-closing adjustments, according to a press release.

As part of the transaction, Bora has assumed responsibility for MacroGenics' manufacturing operations supporting clinical and commercial production. MacroGenics' manufacturing site in Rockville, Maryland, and a warehouse in Frederick, Maryland, have transferred to Bora. Approximately 140 former MacroGenics employees have been hired by Bora.

MacroGenics has entered into a supply agreement with Bora under which Bora

MacroGenics sells GMP manufacturing unit to Bora for $122.5M

Thu, 02 Jul 2026 09:25:23 -0400

MacroGenics has entered into a supply agreement with Bora under which Bora

MacroGenics sells GMP manufacturing unit to Bora for $122.5M

Thu, 02 Jul 2026 09:25:23 -0400

MacroGenics has entered into a supply agreement with Bora under which Bora

MacroGenics sells GMP manufacturing unit to Bora for $122.5M

Thu, 02 Jul 2026 09:25:23 -0400

MacroGenics has entered into a supply agreement with Bora under which Bora

MacroGenics sells GMP manufacturing unit to Bora for $122.5M

Thu, 02 Jul 2026 09:25:13 -0400

MacroGenics has entered into a supply agreement with Bora under which Bora

MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals